R-CHOP Best for Mantle Cell

R-CHOP Best for Mantle Cell

In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone) followed by maintenance therapy…

More...
World Lymphoma Awareness Day

World Lymphoma Awareness Day

Thank you to everyone who helped make WLAD 2012 a success by doing their part, big or small, in helping…

More...
T-Cell Lymphoma Phase 3 Trial

T-Cell Lymphoma Phase 3 Trial

A new trial is underway for relapsed cutaneous T-Cell lymphoma.  About 124 patients will be enrolled in this global, multi-center…

More...
B-Cell Clinical Trial Results

B-Cell Clinical Trial Results

Results from preliminary data from two early-phase clinical trials of the investigational drug, ibrutinib, may benefit some patients with diffuse…

More...
Frontpage Slideshow | Copyright © 2006-2011 JoomlaWorks Ltd.

LATEST LYMPHOMA NEWS

  • Misdiagnoses still prevalent in lymphomas – results from Global Patient Survey

    Misdiagnosis, incorrect medication and treatment, and time to correct diagnosis, are serious issues that still plague the healthcare community when dealing with patients who exhibit lymphoma symptoms.


    Read more...
  • Mayo Clinic: Exhaustion Renders Immune Cells Less Effective in Cancer Treatment

    Rather than stimulating immune cells to more effectively battle cancerous tumors, treatment with the protein interleukin-12 (IL-12) has the opposite effect, driving these intracellular fighters to exhaustion, a Mayo Clinic study has found.


    Read more...

WHAT’S HAPPENING AROUND THE WORLD

RESEARCH

  • 2012 Global Survey Results

    In early 2012, the Lymphoma Coalition launched an on-line global survey to its 54 member organizations and their local members to help them gain a better understanding of and determine the accuracy of what they believe are the following growing concerns affecting lymphoma patients around the world.

    Read more...  
  • 2012 InterLymph Report

    The 2012 Annual Scientific Meeting of the InterLymph Consortium was held from 7-9th June in Bethesda, Maryland at the National Institutes of Health. The meeting was supported by the Lymphoma Coalition and the National Cancer Institute’s Intramural Division of Cancer Epidemiology and Genetics.

    Read more...  

 
The information on this website is for general use only. Please consult your physician if you think you may have lymphoma or require more detailed information on the best course of treatment for you.

UPCOMING EVENTS

Featured Video

More Videos